There is a well-established heterogeneity in BC subtypes with presence, absence or a combination of estrogen receptor alpha (ER ), human epidermal growth factor receptor (HER) and progesterone receptors (PR), that dictate treatment strategies. Here, PGR is linked to breast cancer.